Evidence mapPaperPMID 40779335Full record

ReviewClinical journal of the American Society of Nephrology : CJASN2026

Dietary Advanced Glycation End Products and Cardiovascular-Kidney-Metabolic Complications.

Jaime Uribarri, Katherine R Tuttle

Abstract readReview
In one paragraph

Review in Clinical journal of the American Society of Nephrology : CJASN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jaime UribarriRenal Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.ORCID 0000-0001-9826-1134
Katherine R TuttleProvidence Medical Research Center, Providence Inland Northwest Health, Spokane, Washington.ORCID 0000-0002-2235-0103

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular-kidney-metabolic (CKM) syndrome is a new term indicating a health condition that emphasizes the interconnection of diabetes (type 2 diabetes [T2D]), insulin resistance (IR), CKD, and cardiovascular disease; the pathogenic links between these conditions seem to start with IR/T2D. The incidence and prevalence of this condition are increasing in parallel with the contemporary Western culture consumption of ultra-processed foods. Thermic processing of food increases the formation of pro-oxidant and proinflammatory advanced glycation end products (AGEs), which are partially absorbed into the body increasing the body pool of AGEs, which eventually produces chronic tissue injury, including IR. In this article, we review the literature and present experimental and human data supporting the hypothesis that AGEs in food are major contributory factors to toxicity of ultra-processed foods. We postulate that although hyperglycemia accompanying the diabetic state increases endogenous AGE production, ingestion of these compounds in food may also initiate oxidative stress that eventually causes IR and T2D. Several small clinical trials have studied the effect of dietary AGE intake restriction over variable periods of time, and most of them have demonstrated significant reduction not only in circulating markers of AGEs but also in markers of inflammation and oxidative stress in healthy as well as in CKM subjects. An AGE-restricted diet has also been shown to improve markers of IR. Final proof of a therapeutic role for the low AGE diet will require large, prospective, and randomized clinical trials, which may be challenging to accomplish. We believe, however, that current available data make it reasonable and prudent to advise limitation of dietary AGEs in the general population as well as in CKM patients. Importantly, the simple changes in culinary techniques suggested here can markedly affect AGE content in food and be incorporated as meal patterns consistent with most currently available recommendations promoting CKM health.

Indexed as

Cardiovascular DiseasesDiabetes Mellitus, Type 2DietGlycation End Products, AdvancedMetabolic SyndromeAnimalsDietary Advanced Glycation End ProductsHumansInsulin ResistanceOxidative StressDietary Advanced Glycation End ProductsGlycation End Products, Advancedadvanced glycation end productcardiovascular diseaseCKD nondialysisdiabetes mellitusinsulin resistancenutrition

Identifiers

PMID40779335
PMCPMC12889920

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.